palmidrol has been researched along with Burning Mouth Syndrome in 1 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
Burning Mouth Syndrome: A group of painful oral symptoms associated with a burning or similar sensation. There is usually a significant organic component with a degree of functional overlay; it is not limited to the psychophysiologic group of disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ottaviani, G | 1 |
| Rupel, K | 1 |
| Gobbo, M | 1 |
| Poropat, A | 1 |
| Zoi, V | 1 |
| Faraon, M | 1 |
| Di Lenarda, R | 1 |
| Biasotto, M | 1 |
1 trial available for palmidrol and Burning Mouth Syndrome
| Article | Year |
|---|---|
Efficacy of ultramicronized palmitoylethanolamide in burning mouth syndrome-affected patients: a preliminary randomized double-blind controlled trial.
Topics: Aged; Aged, 80 and over; Amides; Burning Mouth Syndrome; Double-Blind Method; Ethanolamines; Female; | 2019 |